inter partes review

Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Fri, 08/30/19 - 01:00 pm
Amgen
Alexion
inter partes review
patents
Soliris
Biopharma gets better chance to protect patents during inter partes review
BioCentury
Wed, 03/27/19 - 11:33 pm
USPTO
patents
inter partes review
Mylan takes step toward knocking down key patent for Biogen's top-seller
Biopharma Dive
Thu, 02/7/19 - 03:26 pm
Mylan
Biogen
Tecfidera
patents
inter partes review
Tribe, Allergan appeal sovereign immunity patent case to Supreme Court
BioCentury
Wed, 01/16/19 - 12:04 am
Allergan
Supreme Court
inter partes review
Inter Partes Review to be more favorable to biotech
BioCentury
Thu, 10/11/18 - 11:01 pm
PTO
inter partes review
Federal judges ban Allergan’s sovereign immunity scheme in a slapdown that will bolster inter partes review for years to come
Endpoints
Sat, 07/21/18 - 02:03 pm
Allergan
patents
Restasis
inter partes review
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Endpoints
Fri, 03/9/18 - 11:05 am
Senate
Allergan
patents
Restasis
inter partes review
Mylan Announces IPR Proceedings for Sanofi's Lantus Patents
Yahoo/Zacks.com
Fri, 12/15/17 - 11:45 pm
Mylan Labs
inter partes review
Sanofi
Lantus
patents
diabetes
Supreme Court eyes IPR process
BioPharma Dive
Wed, 11/29/17 - 09:41 pm
IPR
inter partes review
Supreme Court